Accessibility settings

JMIR Diabetes

Emerging technologies, medical devices, apps, sensors, and informatics to help people with diabetes

Editor-in-Chief:

Ricardo Correa, MD, EdD (Co-Editor-in-Chief), Cleveland Clinic, United States

Sheyu Li, MD (Co-Editor-in-Chief), West China Hospital, Sichuan University, China


Impact Factor 2.6 More information about Impact Factor CiteScore 4.7 More information about CiteScore

JMIR Diabetes (JD, ISSN 2371-4379) focuses on technologies, medical devices, apps, engineering, informatics and patient education for diabetes prevention, self-management, care, and cure, to help people with diabetes. JMIR Diabetes may consider papers that do not have a digital health component but represent a significant innovation for diabetes prevention and care.

JMIR Diabetes publishes original research, viewpoints, and reviews (both literature reviews and medical device/technology/app reviews) covering, for example, wearable devices and trackers, mobile apps, glucose monitoring (including emerging technologies such as Google contact lens), medical devices for insulin and metabolic peptide delivery, closed loop systems and artificial pancreas, telemedicine, web-based diabetes education and elearning, innovations for patient self-management and "quantified self", diabetes-specific EHR improvements, clinical or consumer-focused software, diabetes epidemiology and surveillance, crowdsourcing and quantified self-based research data, new sensors and actuators to be applied to diabetes.

As an Open Access journal, JMIR Diabetes is read by clinicians and patients alike and has (as all JMIR Publications journals) a focus on readable and applied science reporting the design and evaluation of health innovations and emerging technologies, as well as on diabetes prevention and epidemiology.

JMIR Diabetes is indexed in PubMed, PubMed Central, DOAJ, Scopus and the Web of Science™ (ESCI).

JMIR Diabetes received an inaugural Journal Impact Factor of 2.6 according to the latest release of the Journal Citation Reports from Clarivate, 2025.

With a CiteScore of 4.7 (2024), JMIR Diabetes is a Q2 journal in the field of Health Informatiion Management, according to Scopus data.

 

 

Recent Articles

Woman using tablet at table with fruit and coffee
Diabetes Self-Management

The prevalence of diabetes in the United States necessitates investigations into how to better enable adults with type 2 diabetes mellitus (T2DM) to manage their health using easy-to-access and personally adaptable technologies. The ubiquity of digital content further justifies the need to consider the impact of different digital intervention modalities in diabetes self-care activities.

Man checks diabetes app on phone, glucose 112 mg/dL
Apps, Mobile, Wearables for Diabetes

Diabetes mellitus is a chronic metabolic disorder marked by elevated blood glucose levels and has emerged as a global epidemic that requires management strategies for effective glycemic control through diet. In recent years, mobile apps have emerged as valuable tools for supporting self-management in chronic diseases such as diabetes, particularly for the nutritional aspects of the disease. However, the quality, accuracy, and adherence of these apps to established dietary guidelines remain underexplored and inconsistent.

Family preparing healthy meals with fresh vegetables and meal prep containers.
Reviews on Diabetes Technologies and Innovations

Gestational diabetes mellitus (GDM) requires effective self-management to mitigate associated health risks. A comprehensive understanding of the multilevel factors influencing adherence is essential to designing effective, holistic support strategies.

Doctor shows patient tablet with heart diagram, discussing cardiology.
Diabetes-specific EHR Improvements

Cardiovascular-kidney-metabolic (CKM) syndrome is a multisystem construct describing the intertwined progression of cardiometabolic risk factors, chronic kidney disease (CKD), and cardiovascular disease. The American Heart Association (AHA) proposed CKM stages (0‐4) for risk stratification and prevention. However, CKM lacks a single () code, which hinders standardized stage identification in electronic health records and claims data.

Woman holding smartphone displaying a diabetes management app for young people
Apps, Mobile, Wearables for Diabetes

Individuals living with type 1 diabetes (T1D) are at an increased risk of experiencing psychological distress; however, there remains a scarcity of scalable and widely accessible support services, particularly for adolescents and young adults. To address this gap, digital mental health interventions are becoming an increasingly important area of innovation in diabetes care.

Woman using a glucose meter to check blood sugar levels at home.
Diabetes Surveillance and Epidemiology

The triglyceride-glucose (TyG) index has demonstrated promising predictive capability in clinical studies, but its distribution characteristics across different age and sex groups in the Chinese population have not been fully characterized.

Doctor giving patient two white pills in a medical office
Artificial Intelligence in Diabetes Care and Prevention

The rate of treatment failure with sodium-glucose cotransporter-2 inhibitors (SGLT2i) is high among individuals with type 2 diabetes (T2D). Accurately predicting SGLT2i treatment failure is important for improving the clinical management of T2D.

Young woman holds up a glucose meter, indicating diabetes management
Diabetes Self-Management

Participating in a Diabetes Self-Management Education and Support (DSMES) program improves self-care behaviors, quality of life, and health outcomes. However, language barriers and cultural differences can hinder participation, leaving many Vietnamese Americans with limited access to DSMES services.

Man with diabetes applying a continuous glucose monitor (CGM) on his arm.
Reviews on Diabetes Technologies and Innovations

Conventional clinical markers guide cardiovascular risk stratification; however, continuous glucose monitoring (CGM) data remain absent from prediction models. A synthesis of the current literature is needed to clarify the prognostic relevance of CGM data for cardiovascular outcomes in people with diabetes.

Team analyzing charts and graphs during a business meeting, pointing at data.
Diabetes Self-Management

Many persons with type 2 diabetes (T2D) lack risk awareness or underestimate their cardiovascular risk. Although health care professionals in primary health care strive to implement risk-awareness strategies for cardiovascular risk, persons with T2D report a lack of meaningful dialogue with health care professionals. Co-creation is grounded in participatory action research and involves participants as equal partners across all stages of a project. This study describes the development of an intervention to increase cardiovascular risk awareness in people with T2D.

We are working in partnership with